EMSella: Pelvic Floor Science Explained

For many people in Burnaby and the Greater Vancouver area, urinary incontinence and pelvic floor weakness are deeply personal concerns — ones that affect daily confidence, physical activity, and intimate relationships. EMSella offers a non-invasive, clinically supported path to addressing these issues. If you are researching whether this treatment is right for you, this article dives into the science, evidence, and clinical considerations behind the technology. Learn more about EMSella for a full overview of how we offer this treatment at SkinArtMD.

What Is EMSella and How Does It Work?

EMSella is a High-Intensity Focused Electromagnetic (HIFEM) therapy device designed specifically for pelvic floor rehabilitation. It delivers focused electromagnetic energy through a specially designed chair, inducing thousands of supramaximal pelvic floor muscle contractions during a single 28-minute session — contractions far exceeding what voluntary exercise can achieve.

The Mechanism of Action: HIFEM Technology

The electromagnetic field generated by EMSella penetrates through clothing and tissue, directly stimulating the motor neurons of the pelvic floor musculature. At peak intensity, the device induces approximately 11,000 contractions per session.

At the cellular level, repeated supramaximal contractions trigger several key adaptations:

• Myofibril hypertrophy: Muscle fiber enlargement through increased actin-myosin cross-bridge cycling
• Neuromuscular re-education: Restoration of coordinated motor unit recruitment patterns, which is critical in stress urinary incontinence (SUI) where fast-twitch fiber response is impaired
• Connective tissue remodeling: Increased collagen and elastin synthesis in the pelvic fascia and ligaments supporting the bladder neck and urethra
• Improved resting tone: Sustained low-level activation that maintains baseline support between contractions

This differs mechanistically from electrical stimulation (e-stim) devices, which activate superficial nerve pathways. HIFEM penetrates deeper tissue layers without surface electrode contact, allowing whole-muscle recruitment rather than isolated fiber groups.

Clinical Evidence Summary

The evidence base for HIFEM pelvic floor therapy has grown substantially. Multiple peer-reviewed trials have examined its efficacy across different patient populations.

Stress and Mixed Urinary Incontinence

Gilling et al., published in Neurourology and Urodynamics, conducted a randomized sham-controlled trial examining HIFEM therapy in women with stress or mixed urinary incontinence. The study demonstrated statistically significant reductions in incontinence episodes and pad use, alongside objective improvements in pelvic floor muscle strength measured by perineometry.

Samuels et al., in the International Urogynecology Journal, reported a prospective cohort study tracking patients through a standard six-session protocol. Findings showed meaningful reductions in International Consultation on Incontinence Questionnaire (ICIQ) scores — a validated patient-reported outcome tool — and improvements sustained at three-month follow-up.

Silantyeva et al., in the Journal of Women's Health, evaluated HIFEM versus pelvic floor physical therapy in a comparative design. Both groups showed improvement, but the HIFEM cohort achieved equivalent outcomes in shorter time and with higher patient compliance — a clinically relevant finding for patients who struggle with adherence to home exercise regimens.

Emerging Evidence in Postpartum Recovery and Prolapse

Additional research has explored EMSella-class HIFEM therapy in postpartum pelvic floor recovery and early-stage pelvic organ prolapse. While the evidence in these areas is earlier-stage, preliminary data suggests benefits in pelvic floor coordination and subjective symptom reduction. Consistent across studies is a favorable safety profile, with no serious adverse events reported in published trials.

Quality-of-Life Outcomes

Across studies, quality-of-life improvements — measured by tools such as the ICIQ-SF and King's Health Questionnaire — consistently parallel objective findings. Patients report improved confidence, reduced limitation in physical activities, and better sexual function. These patient-centered outcomes are increasingly recognized as co-primary endpoints in urogynecology research.

Regulatory Approval Status

EMSella has received clearance from both Health Canada and the U.S. Food and Drug Administration (FDA) for the treatment of urinary incontinence and improvement of quality of life in patients. This regulatory status distinguishes it from many wellness-only devices and underpins its use in physician-supervised clinical settings.

EMSella vs. Adjacent Pelvic Floor Treatments

Understanding EMSella's clinical niche requires situating it within the broader landscape of pelvic floor interventions.

Key differentiators:

EMSella produces supramaximal contractions exceeding 100% of voluntary maximum — a level patients with already-weakened pelvic floors cannot generate through Kegel exercises alone. The fully clothed, seated format lowers practical and psychological barriers compared to intravaginal or surgical options. The standard six-session protocol completes in three weeks, enabling quicker clinical assessment of patient response versus prolonged physiotherapy courses.

EMSella is often used as a standalone treatment or in combination with pelvic floor physiotherapy, depending on severity and individual goals. Book a Consultation to discuss which approach fits your situation.

Candidate Evaluation: Who Benefits Most?

Not every patient with urinary leakage is an ideal EMSella candidate. Physician-led evaluation is essential to identify the urinary incontinence subtype and confirm HIFEM suitability.

Ideal Candidates

• Stress urinary incontinence (SUI): Leakage triggered by coughing, sneezing, laughing, or exercise — the defining presentation of sphincter and levator ani weakness
• Mixed urinary incontinence: SUI component present alongside urgency-type symptoms
• Postpartum pelvic floor rehabilitation: Vaginal delivery frequently disrupts pelvic floor integrity; EMSella offers a non-gynecologic pathway to recovery
• Perimenopause and menopause: Estrogen decline reduces tissue integrity; EMSella may complement hormonal or topical therapies
• Patients seeking non-surgical options: Those who have not responded adequately to exercise alone but wish to avoid surgery or intravaginal procedures

Less Ideal Candidates

• Pure urgency urinary incontinence (UUI): Driven primarily by detrusor overactivity (overactive bladder), not sphincter weakness. EMSella may offer partial benefit but is not the primary indicated therapy.
• Overflow incontinence or neurogenic bladder: Underlying etiology requires specialist management; HIFEM does not address structural or neurological causes.
• Severe pelvic organ prolapse (Stage III–IV): Structural correction may be needed before or instead of HIFEM.

At SkinArtMD in Burnaby, all EMSella candidates undergo a structured intake and consultation. Dr. Sharon Fong, a CPSBC-registered physician specializing in medical aesthetics and non-invasive procedures, leads the candidate evaluation process — ensuring every patient is assessed for appropriateness before any treatment plan is confirmed. Book a Consultation to begin your evaluation.

What to Expect: The Treatment Protocol

EMSella is delivered in a series of sessions — the standard protocol is six sessions over three weeks, with two sessions per week. Each session is approximately 28 minutes.

Step-by-step process:

1. Patient arrives fully clothed and is seated on the EMSella chair
2. Chair settings are calibrated to patient comfort and clinical goals
3. Electromagnetic pulses begin — patients feel a distinct tingling and involuntary muscle contraction, typically described as an intense rhythmic sensation rather than pain
4. Intensity is gradually increased to therapeutic levels over the first several minutes
5. Session concludes; no downtime or wound care required

Many of our patients across Greater Vancouver return to work or daily activities immediately after each session. There is no recovery period, no activity restriction, and nothing to apply or manage afterward.

Timeline and Results

Clinical improvement in pelvic floor tone and incontinence frequency typically begins emerging from sessions three and four onward. Maximum effect is usually assessed at six to eight weeks after completing the full protocol, once muscle remodeling has had time to stabilize. Individual responses vary based on baseline pelvic floor status, age, delivery history, and hormonal factors.

Maintenance sessions — typically once every three to six months — can help sustain results over time. Our team will provide a personalized maintenance recommendation based on your initial response.

Limitations and Contraindications

EMSella is a powerful clinical tool, but it has clearly defined limits.

Absolute Contraindications

• Metal implants in the pelvic region: Metallic IUDs, pelvic surgical hardware, or implanted nerve stimulators (e.g., sacral neuromodulation devices) are contraindicated due to electromagnetic interaction
• Cardiac pacemakers or implantable defibrillators
• Active pregnancy
• Malignancy in or near the pelvic treatment area

Relative Considerations

• Copper IUDs: Non-metallic IUDs (hormonal, plastic) are generally acceptable; copper IUDs require physician and manufacturer guidance before proceeding
• Anticoagulant therapy: No incisional risk is present, but full patient history should be reviewed
• Severely atrophied or denervated muscle: Markedly reduced neuromuscular response may limit treatment effect in advanced cases

Clinical Limitations

EMSella strengthens the muscular and connective tissue layer of the pelvic floor — it does not address detrusor overactivity, neurological causes of incontinence, or anatomical abnormalities requiring surgical correction. Results require the muscle to respond to electromagnetic stimulus. Without continued neuromuscular engagement through maintenance sessions, gradual return toward baseline tone can occur over time.

Why Choose SkinArtMD?

Many of our clients in Burnaby come to SkinArtMD specifically because they want physician-supervised care — not just a device operator. Here is what distinguishes our approach:

• Physician-led evaluation: Every EMSella candidate is assessed by our medical team before a single session is booked. This ensures you are a true candidate and that your treatment plan is built around your specific presentation.
• Integrated aesthetic and functional care: For patients navigating both pelvic floor changes and other menopausal or postpartum concerns, we can coordinate a broader plan addressing multiple goals within one practice.
• Bilingual care: Our team serves patients in both English and Mandarin Chinese (普通话) — an important consideration for many Greater Vancouver families navigating sensitive health topics.
• Health Canada-cleared technology: We use EMSella as part of a carefully selected device portfolio chosen for regulatory approval and published patient evidence.

Patients often tell us that the seated, clothed, and private nature of EMSella made them willing to finally seek help for a concern they had been living with silently for years. That matters to our team.

Frequently Asked Questions

Is EMSella painful? Most patients describe the sensation as unusual rather than painful — a strong, rhythmic involuntary contraction. Intensity is adjusted to patient tolerance and most find it comfortable once the first few minutes of calibration pass.

How many sessions will I need? The standard protocol is six sessions over three weeks. Some patients with more significant baseline pelvic floor weakness may benefit from additional sessions. Individual plans are determined at consultation.

Will I see results after the first session? Some patients notice subtle improvement early, but meaningful clinical results typically build across the full protocol. Maximum effect is generally visible six to eight weeks after the last session, once tissue remodeling has stabilized.

Can EMSella be combined with other treatments? Yes. EMSella can complement pelvic floor physiotherapy, hormonal therapy, or other non-invasive pelvic treatments. Our physician team can advise on appropriate combination protocols based on your goals.

Is EMSella covered by insurance in BC? As an elective medical aesthetic treatment, EMSella is generally not covered by BC MSP or extended health benefits. Contact us for current pricing and available package options.

Is EMSella only for women? While most published research focuses on women, HIFEM pelvic floor therapy has also been studied in men — particularly for post-prostatectomy incontinence. Discuss eligibility at your consultation.

How do I know if I have stress versus urgency incontinence? This distinction requires a clinical history and sometimes urodynamic testing. It is the primary reason we require a physician consultation before booking — incontinence subtype matters significantly for treatment selection.

Next Steps

If you have been researching EMSella and recognize yourself in the candidate profile described above, the next step is a one-on-one consultation with our physician team. At SkinArtMD in Burnaby, we will review your history, confirm your incontinence subtype, and build a realistic treatment plan with clear timelines and expectations. Book a Consultation today — available in English and Mandarin Chinese.

Ready to See What EMSella Can Do for You?

Our medical team at SkinArtMD in Burnaby is ready to create your personalized treatment plan. Book your complimentary consultation today — available in English and Chinese.

This article is for educational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional before undergoing any treatment.